首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2955780篇
  免费   221497篇
  国内免费   6184篇
耳鼻咽喉   42311篇
儿科学   97518篇
妇产科学   84436篇
基础医学   424488篇
口腔科学   84214篇
临床医学   260457篇
内科学   577192篇
皮肤病学   65535篇
神经病学   236947篇
特种医学   113626篇
外国民族医学   1079篇
外科学   451070篇
综合类   66968篇
现状与发展   4篇
一般理论   955篇
预防医学   228989篇
眼科学   69071篇
药学   215756篇
  2篇
中国医学   6255篇
肿瘤学   156588篇
  2018年   31380篇
  2017年   23913篇
  2016年   26716篇
  2015年   30263篇
  2014年   42968篇
  2013年   64643篇
  2012年   87985篇
  2011年   93939篇
  2010年   55793篇
  2009年   52607篇
  2008年   88219篇
  2007年   94088篇
  2006年   95203篇
  2005年   92863篇
  2004年   89032篇
  2003年   85510篇
  2002年   83438篇
  2001年   133776篇
  2000年   137193篇
  1999年   116040篇
  1998年   33743篇
  1997年   30378篇
  1996年   30336篇
  1995年   28620篇
  1994年   26492篇
  1993年   24921篇
  1992年   90900篇
  1991年   88184篇
  1990年   86128篇
  1989年   83032篇
  1988年   77010篇
  1987年   75522篇
  1986年   71755篇
  1985年   68646篇
  1984年   51887篇
  1983年   44521篇
  1982年   26896篇
  1981年   23882篇
  1979年   48058篇
  1978年   34042篇
  1977年   28805篇
  1976年   27383篇
  1975年   29533篇
  1974年   35225篇
  1973年   33952篇
  1972年   32100篇
  1971年   29679篇
  1970年   28080篇
  1969年   26482篇
  1968年   25040篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
Graefe's Archive for Clinical and Experimental Ophthalmology - The published online version contains mistake as the author's first name and last name have been interchanged as "Hild...  相似文献   
34.
35.
There is a sharp difference in how one views TCR structure–function–behaviour dependent on whether its recognition of major histocompatibility complex‐encoded restriction elements (R) is germline selected or somatically generated. The generally accepted or Standard model is built on the assumption that recognition of R is by the V regions of the αβ TCR, which is not driven by allele specificity, whereas the competing model posits that recognition of R is allele‐specific. The establishing of allele‐specific recognition of R by the TCR would rule out the Standard model and clear the road to a consideration of a competing construct, the Tritope model. Here, the case for allele‐specific recognition (germline selected) is detailed making it obvious that the Standard model is untenable.  相似文献   
36.
37.
BACKGROUND The adenoma detection rate(ADR) is inversely associated with the incidence of interval colorectal cancer and serves as a benchmark quality criterion during screening colonoscopy. However, adenoma miss rates reach up to 26% and studies have shown that a second inspection of the right colon in retroflected view(RFV) can increase ADR.AIM To assess whether inspection of the whole colon in RFV compared to standard forward view(SFV) can increase ADR.METHODS Patients presenting for screening or surveillance colonoscopy were invited to participate in this randomized controlled trial and randomized into two arms. In RFV arm colonoscopy was initially performed with SFV, followed by a second inspection of the whole colon in RFV. In the SFV arm first withdrawal was performed with SFV, followed by a second inspection of the whole colon again with SFV. Number, size and morphology of polyps found during first and second inspection in each colonic segment were recorded and all polyps were removed and sent for histopathology in separate containers.RESULTS Two hundred and five patients were randomly assigned to the RFV(n = 101) and SFV(n = 104) arm. In the RFV arm, both polyp detection rate(PDR) and ADR were increased under second inspection in RFV(PDR 1~(st) SFV: 39.8%, PDR 2~(nd)RFV: 46.6%; ADR 1~(st) SFV: 35.2%, ADR 2~(nd) RFV: 42%). Likewise, in the SFV arm,PDR and ADR were increased under second inspection(PDR 1~(st) SFV: 37.5%, PDR 2~(nd) SFV: 46.6%; ADR 1~(st) SFV: 34.1%, ADR 2~(nd)SFV: 44.3%) with no significant differences in ADR and PDR between the SFV and RFV arm. Mean number of adenomas per patient(APP) was increased in the RFV and SFV(APP RFV arm: 1~(st) SFV: 1.71; 2~(nd) RFV: 2.38; APP SFV arm: 1~(st) SFV: 1.83, 2~(nd)SFV:2.2). The majority of adenomas additionally found during second inspection in RFV or in SFV were located in the transverse and left-sided colon and were 5 mm in size.CONCLUSION Second inspection of the whole colon leads to increased adenoma detection with no differences between SFV and RFV. Hence, increased detection is most likely a feature of the second inspection itself but not of the inspection mode.  相似文献   
38.
39.
To determine percent of patients without malignancy and ≤ 40 years of age with high cumulative radiation doses through recurrent CT exams and assess imaging appropriateness. From the cohort of patients who received cumulative effective dose (CED) of ≥ 100 mSv over a 5-year period, a sub-set was identified with non-malignant disease. The top 50 clinical indications leading to multiple CTs were determined. Clinical decision support (CDS) system scores were analyzed using a widely adopted standard of 1–3 (red) as “not usually appropriate,” 4–6 (yellow) “may or may not be appropriate,” and 7–9 (green) “usually appropriate.” Clinicians reviewed patient records to assess compliance with appropriate use criteria (AUC). 9.6% of patients in our series were with non-malignant conditions and 1.4% with age ≤ 40 years. CDS scores (rounded) were 2% red, 38% yellow, 27% green, and 33% unscored CTs. Clinical society guidelines for CT exams, wherever available, were followed in 87.5 to 100% of cases. AUCs were not available for several clinical indications as also referral guidelines for serial CT imaging. More than half of CT exams were unrelated to follow-up of a primary chronic disease. We are faced with a situation wherein patients in age ≤ 40 years require or are thought to require many CT exams over the course of a few years but the radiation risk creates concern. There is a fair number of conditions for which AUC are not available. Suggested solutions include development of CT scanners with lesser radiation dose and further development of appropriateness criteria.  相似文献   
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号